Ex-Sky News presenter Dermot Murnaghan reveals stage 4 prostate cancer diagnosis
The former BBC and Sky News presenter Dermot Murnaghan has been diagnosed with prostate cancer.
The 67-year-old announced his diagnosis on social media, saying it was one of stage four advanced cancer.
Murnaghan said he was 'fortunate to have a simply outstanding medical team' looking after him that was 'administering the best possible care with expertise, compassion and sensitivity … I'm responding positively to their excellent treatment, and feeling well.'
He added: 'Needless to say, my message to all men over 50, in high risk groups, or displaying symptoms, is get yourself tested and campaign for routine prostate screening by the NHS.
'Early detection is crucial. And be aware, this disease can sometimes progress rapidly without obvious symptoms.'
Stage four prostate cancer means that the disease has spread into different parts of the body including nearby organs, such as the back passage or bladder, nearby lymph nodes and other parts of the body outside the pelvis, such as the bones, lungs or liver, according to the Cancer Research UK website.
Murnaghan, who spent more than 15 years at Sky News before his departure in 2023, said he was aiming to take part in Sir Chris Hoy's fundraising charity bike ride in September, which will raise awareness and funds for cancer charities across the UK.
Hoy, the six-time Olympic gold medallist, announced he had a terminal diagnosis for prostate cancer in October 2024.
Murnaghan presents true crime documentary series Killer Britain and the podcast Legends of News.
He presented ITV's News at Ten and the BBC Ten O'Clock News – now known as BBC News at Ten – as well as Channel 4 News.
Murnaghan also hosted the BBC's quiz programme Eggheads.
About one in eight men will get prostate cancer in their lifetime, according to the charity Prostate Cancer UK, and the disease often has no symptoms in its earlier stages.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
an hour ago
- Daily Mirror
GPs' strict rules for prescribing weight loss jab explained
GPs are now able to prescribe Mounjaro injections, but only if patients meet strict guidelines NHS England has announced that GPs will now be able to prescribe Mounjaro injections. Originally licensed for type 2 diabetes treatment, the medication's use as a weight loss aid stems from its appetite-suppressing properties. The health service aims to make these injections widely available, but this is a long-term objective. Starting on Monday, a very limited group of people will be able to get prescriptions for it through their GP. Currently, two criteria must be met to qualify for the prescription. Firstly, a BMI of 40 or over is required, however, if you're from a minority ethnic background, you may be eligible with a BMI of 37.5 or over. Additionally, you'll need to have been diagnosed with four out of the following five conditions: Type 2 diabetes High blood pressure Heart and vascular disease High cholesterol Obstructive sleep apnoea In this initial rollout, it's expected that 220,000 people will be eligible and receive Mounjaro through the NHS in the next three years, according to the Guardian. Previously, patients needed to use special weight loss services to access the medication. As weight loss medication became mainstream news, GP surgeries have reported being overwhelmed with requests for the injections. With these criteria now in the open, GPs are urging people not to approach their local surgery unless they meet the eligibility requirements, according to the BBC. BMI is calculated by comparing your height and weight, with ethnicity factored in for certain risk factors. It has faced criticism for not accounting for muscle mass, which could skew results, but remains the most common method for assessing obesity in healthcare. The NHS provides a complimentary BMI calculator online here. According to this tool, a BMI between 18.5 and 25 is deemed healthy, below 18.5 is underweight, 25 to 30 is overweight, and over 30 is considered obese. The NHS tool also suggests "next steps" for those whose BMI falls outside the healthy range. Even if you are eligible for the jabs, the early days of this rollout could lead to some hiccups as experts have already warned the supply set aside for GP prescriptions won't be enough to satisfy demand. Mounjaro also requires monthly follow-ups, demanding significant time and effort from medical professionals. As a result, GP surgeries will likely be strategising to ensure they don't exceed their capacity. In Wales, the government is deliberating on a primary care rollout, with the injections presently accessible only via specialist weight management services. Northern Ireland, meanwhile, is implementing a regional obesity management service. For people who don't qualify or live in regions where GPs aren't offering the treatment, Dr Xand offered reassurance on Morning Live: "If you think these drugs would help but you don't meet the criteria, I think it's worth saying there are lots of drugs in the pipeline, it is very likely that the price can come down. "It can be frustrating to have to wait. But I think over the next few years, the picture is optimistic for people who want these drugs."
Western Telegraph
an hour ago
- Western Telegraph
At-home tests offered to women to drive down cervical cancer cases
The tests, which can be performed at home, look for the human papillomavirus (HPV) – the virus which is linked to the majority of cases of cervical cancer. After getting the nod from the UK National Screening Committee in March, the NHS in England is going to offer the tests to certain women. It is expected that the rollout will begin in January next year. The NHS offers cervical screening tests – previously known as smear tests – to all women aged 25-64 every three years. But many people do not take up the offer, with a number citing a lack of time, discomfort or embarrassment. Data published by the NHS last November showed five million women are not up to date with routine check-ups. Now officials have said that at-home kits will be offered to women who have rarely or have never attended their cervical screening. The initiative will see women sent a self-sampling kit in the post which can be returned via pre-paid mail. Health Secretary Wes Streeting said the move could break down 'barriers that keep millions of women from potentially life-saving tests' (Lucy North/PA) People who were found to have the HPV virus will be encouraged to attend an in-person appointment with a clinician. Research has suggested that offering DIY testing kits could boost uptake. The YouScreen trial, which was led by King's College London in partnership with NHS England, found that offering self-sampling kits to 'under-screened' women when they attend their GP practice and by posting kits to women's homes could boost uptake in England by about 400,000 each year. The Department of Health and Social Care said the new approach could potentially save about 5,000 lives a year across England. It said that the new programme 'specifically targets those groups consistently missing vital appointments' including: younger women, those from minority ethnic backgrounds, people with disabilities and LGBT plus people. Health and Social Care Secretary Wes Streeting said: 'These self-sampling kits represent healthcare that works around people's lives, not the other way around. 'They put women firmly in control of their own health, ensuring we catch more cancers at their earliest, most treatable stages. 'Our 10-year health plan will fundamentally reform the NHS, shifting focus from treating illness to preventing it before it starts. 'We know the earlier cancer is diagnosed the better the chances are of survival. 'By making screening more convenient, we're tackling the barriers that keep millions of women from potentially life-saving tests.' Dr Anita Lim, chief investigator of the YouScreen trial from King's College London, added: 'This is a significant step forward for cervical cancer prevention and brings us closer to the NHS goal of eliminating the disease by 2040. 'The YouScreen trial, which provided self-sampling HPV kits to under-screen women in London, demonstrated that self-sampling could reach people who find it difficult to attend traditional screening – including those from diverse and underserved populations. 'It's hugely positive to see this now reflected in national policy, helping more people get protected from this highly preventable cancer.' Michelle Kane, NHS England's director of screening, added: 'There are a number of reasons that stop some women taking up the offer of screening and we hope the introduction of self-testing will encourage more women to take up this life-saving test in a way that works for them. 'I'd encourage anyone who gets an invite for a cervical screening, either from their local GP practice or the NHS App, to attend and if you have any worrying symptoms, please contact your GP. It could save your life.'
Western Telegraph
an hour ago
- Western Telegraph
Judi Dench: Government must give people with dementia earlier diagnosis
The Oscar-winning actress is backing a new campaign and petition by Alzheimer's Research UK for people with the condition to be told much quicker if they have it. Almost a million people in the UK are living with dementia, but about one in three do not have a diagnosis. According to Alzheimer's Research UK, people in some parts of England can wait up to a year for a diagnosis after being referred, while those in the most deprived areas face longer delays. Dame Judi said: 'Dementia doesn't just take away memories – it can take away identity, connection, and the future you thought you had. 'Watching loved ones slip away, and not knowing why, is an experience no one should have to go through without answers. 'Many people across the UK are still waiting far too long for a dementia diagnosis – or never receive one at all. 'That means they miss out on vital support, on the chance to plan ahead, opportunities to get involved in research, and on precious time. 'A diagnosis may not fix everything, but it gives people understanding, clarity, and some control at a time when everything feels uncertain. It allows families to make the most of the moments they have left. 'That's why I've signed Alzheimer's Research UK's petition – and why I'm asking the public to do the same. 'Together, we can call on government to fix the crumbling diagnosis system and make sure no one faces dementia unseen.' The new Alzheimer's Research UK campaign, Dementia Unseen, comes after the NHS target to ensure 66.7% of people with dementia receive a diagnosis was removed from NHS planning guidance for 2025-26. Two breakthrough Alzheimer's drugs: lecanemab and donanemab, were rejected for use on the NHS last week. Alzheimer's Research UK is calling for people with suspected dementia to be referred by their GP to see a specialist within six weeks – and to have a diagnosis and treatment plan in place within 18 weeks. Hilary Evans-Newton, chief executive of Alzheimer's Research UK, said: 'Everyone who has dementia should have the right to know the disease or diseases causing it, and to be diagnosed early enough to get treatments that help with its symptoms. 'But hundreds of thousands of people are waiting too long for a diagnosis, causing uncertainty, and adding distress to an already challenging situation. 'We're incredibly grateful to Dame Judi for helping shine a light on what people with dementia need – and to everyone who has already signed our petition and stands with us. 'More people are seeking answers, so it's vital that the NHS and government act now to fix the system – because no one should face dementia alone or unseen.' The petition is at Professor Fiona Carragher, chief policy officer at Alzheimer's Society, said: 'Everyone living with dementia deserves the clarity and dignity of an early and accurate diagnosis. Yet, more than a third of people living with this terminal condition are in the dark because they haven't been diagnosed, with many left to struggle alone without the care, support and treatment a diagnosis can bring. 'In fact, on average people experience dementia symptoms for three and a half years before they receive a diagnosis. 'For some time, we've been calling on the UK Government to urgently address dementia diagnosis and we welcome the recommendations in this new report. 'In particular, we support the call for health services to have the right teams and technology they need to diagnose more people, and for more data on diagnosis so that resources can be targeted where they're needed most. 'The science for dementia treatments is flying but the diagnosis system is failing. It is crucial governments invest in diagnosis across England, Wales and Northern Ireland so people can access the existing treatments of today, plan for the future, and be eligible for the life-changing treatments of tomorrow. 'If our governments set bold and ambitious new dementia diagnosis rate targets to get more people diagnosed, this would bring significant benefits for individuals, their families, and for health and care services.'
